11:51 AM EST - Spectral Medical Inc., : Has entered into a non-exclusive agreement with Fresenius Medical Care Deutschland GmbH to distribute Spectral's FDA approved rapid test for the assessment of endotoxin activity in human whole blood in eight European countries. Spectral Medical Inc.,
shares T.EDT are trading up $0.01 at $0.81.
